Intel Foundrys Apple Deal|at 119x PE, what holds

The Divorce That Became a Negotiation

Intel surged 116% in one month, and the prevailing read is that the Apple foundry deal explains it — but that framing misses what made the deal structurally possible in the first place.

Apple cut Intel out of its Mac lineup in 2020, a break that cost Intel billions in annual revenue and forced a brutal reckoning with its manufacturing infrastructure. The conventional read was that Intel lost Apple because its chips fell behind. The less obvious read is that Apple's exit actually forced Intel to rebuild its foundry business from scratch — and that rebuilding is what put Apple back at the negotiating table.

The preliminary agreement reported by the WSJ is not for Intel x86 processors. Apple is reportedly holding out for Intel's 14A node, which does not enter mass production until 2027 and won't launch broadly until mid-2028. That two-year gap is the detail most coverage glosses over, because it means the deal that sent Intel up 19% in a single session has not yet produced a single chip — and may not for years.

What it has produced is a capital repositioning. Intel trading at 119 times forward earnings is not a valuation built on current cash flows. It is a bet on whether Intel 14A becomes the process node that recaptures foundry customers TSMC cannot accommodate. The question that framing opens is why Apple — flush with $4.21 trillion in market cap and perfectly functional TSMC supply — would take a two-year bet on a node that doesn't exist yet.

Why Apple Needs Intel More Than the Headline Suggests

Apple's TSMC dependence is the supply chain risk that its record $111 billion quarter cannot hedge away, and the Intel deal is the first structural move toward reducing that exposure.

Apple's fiscal Q2 revenue grew 17% year over year. iPhone revenue hit $57 billion, up 22%. Services reached a record $31 billion. Those numbers signal a company generating demand faster than its supply chain can safely absorb — and Tim Cook's warning about rising memory costs is the tell that Apple's cost structure is already under pressure from concentrated supplier leverage.

The counter-signal that changes the implication: Apple is not just diversifying for risk management. Cook described Mac as a leading platform for developers running AI on-device, and Wedbush's Dan Ives set a $400 price target — the highest from any major firm — citing WWDC 2026 as an AI inflection point. If Apple's next hardware cycle is built around on-device AI, the chip architecture underneath those devices becomes a strategic variable, not just a procurement line item.

Intel 14A uses manufacturing equipment that no other foundry currently deploys. If that process node delivers on its yield and performance targets, Apple gets a chip it cannot source anywhere else — which means the Intel deal is less about supply chain redundancy and more about securing a hardware moat before the on-device AI cycle peaks. That reframes the two-year wait from a liability into a deliberate timing decision.

What that reframing does not resolve is whether Intel can actually deliver a node at the frontier when its last several nodes arrived late and underperformed.

The Execution Gap Intel Has Not Closed

Intel's 18A node entering mass production is the proof-of-concept the market has been waiting on, but Microsoft's order for 18A is the condition that separates validation from momentum — and Apple reportedly bypassed 18A entirely.

Leopold Aschenbrenner's Situational Awareness Fund took 20.2 million call options in Intel in Q1 2025 — before the Apple news, before the 116% run. The same analytical framework that flagged energy infrastructure bottlenecks identified Intel's domestic foundry capacity as a structural scarcity. The CHIPS Act has since disbursed $5.7 billion to Intel, and NVIDIA and SoftBank have committed $5 billion and $2 billion respectively in equity. That capital stack is not speculative — it is the scaffolding being assembled around a bet that Intel 14A performs.

But Intel's 14-day RSI hit 80.5 on May 7, and the average analyst price target sits at $80.93 against a stock trading at $125. That 36% implied downside does not mean analysts are wrong about Intel's long-term positioning. It means the market has priced in a scenario where 14A delivers, Apple signs a final contract, and Intel's foundry revenue line re-rates — all before any of those conditions have been confirmed.

The threshold that separates the current rally from a durable re-rating is not the Apple deal becoming official. It is Intel 14A entering production on schedule in 2027 with yields that justify Apple's decision to wait. If 14A slips or underdelivers, the $125 print becomes the ceiling, not the floor, and the 119x P/E multiple compresses violently back toward the $80.93 analyst consensus.

The asymmetry that remains is this: Intel's EMIB-T packaging technology is already being offered externally, CoWoS capacity is structurally constrained through 2027, and Google's Xeon partnership and NVIDIA's DGX Rubin CPU selection suggest foundry credibility is accumulating on multiple fronts simultaneously — not just through the Apple headline.

What 2027 Has to Confirm

The capital that moved into Intel this month is not pricing the current business — it is pricing a 2027 delivery date, and that date is the Chekhov anchor the entire rally rests on.

Apple's 52-week high of $289.18 was reached before the Intel deal was even confirmed. The stock moved on the AI narrative building into WWDC 2026, not on foundry diversification. That means Apple's re-rating and Intel's re-rating are running on separate causal tracks — the Intel deal is additive to Apple's thesis, not foundational to it. If WWDC disappoints on AI, Apple's price action does not depend on whether the Intel foundry agreement converts to a signed contract.

For Intel, the scenario branching is narrower. The bull path requires 14A to enter production in 2027 on schedule, Apple to sign a final agreement, and Intel's foundry revenue to grow faster than the current 119x multiple assumes — which is an extraordinarily high bar. The recovery path, even if 14A is delayed, runs through EMIB-T capturing CoWoS overflow demand as AI packaging constraints tighten through 2027, combined with the Google and NVIDIA revenue streams that are already contracted. That path does not justify $125, but it does create a floor well above the $80.93 analyst consensus.

The single condition that collapses both paths simultaneously is an Intel 14A yield failure — not a delay, but a process node that cannot scale. That outcome would invalidate not just the Apple deal but the entire domestic foundry thesis that CHIPS Act capital, NVIDIA equity, and Aschenbrenner's fund have already underwritten. Intel at 119x forward P/E is a bet that 2027 confirms, not just continues, what 2026 has set up.